🔥🐔 BizChicken 🐔🔥
Companies Similar to IN8bio, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
ImmunityBio, Inc.
Therapies and Vaccines
Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.
Symbol: IBRX
Recent Price: $2.68
Industry: Biotechnology
CEO: Mr. Richard Gerald Adcock
Sector: Healthcare
Employees: 622
Address: 3530 John Hopkins Court, San Diego, CA 92121
Phone: 858 633 0300
Last updated: 2024-12-31
INmune Bio, Inc.
INKmune
INmune Bio, Inc. is a clinical-stage immunotherapy company focused on developing drugs to reprogram the patient's innate immune system for the treatment of hematologic malignancies, solid tumors, chronic inflammation, and Alzheimer's disease.
Symbol: INMB
Recent Price: $4.65
Industry: Biotechnology
CEO: Dr. Raymond Joseph Tesi M.D.
Sector: Healthcare
Employees: 11
Address: 225 NE Mizner Boulevard, Boca Raton, FL 33432
Phone: 858 964 3720
Last updated: 2024-12-31
Inhibrx Biosciences, Inc.
Therapeutic Candidates (INBRX-109, INBRX-106)
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops biologic therapeutics for life-threatening conditions, with therapeutic candidates in phase 2 clinical trials targeting various cancers.
Symbol: INBX
Recent Price: $15.14
Industry: Biotechnology
CEO: Mr. Mark Paul Lappe
Sector: Healthcare
Employees: 166
Address: 11025 North Torrey Pines Road, La Jolla, CA 92037
Phone: 858-795-4220
Last updated: 2024-12-31
Adicet Bio, Inc.
ADI-001
Adicet Bio, Inc. is a biotechnology company focused on discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Their lead product ADI-001 is in Phase I clinical study for non-Hodgkin's lymphoma, with additional products in development for solid tumors.
Symbol: ACET
Recent Price: $0.90
Industry: Biotechnology
CEO: Mr. Chen Schor BA, CPA, M.B.A.
Sector: Healthcare
Employees: 143
Address: 200 Clarendon Street, Boston, MA 02116
Phone: 650 503 9095
Last updated: 2024-12-31
Atara Biotherapeutics, Inc.
T-cell immunotherapy treatments
Atara Biotherapeutics, Inc. is a company focused on developing off-the-shelf T-cell immunotherapy treatments for patients with cancer, autoimmune, and viral diseases, including tabelecleucel for EBV driven diseases, next-generation CAR T therapies, and the ATA368 program for HPV associated cancers.
About | About | About | Contact | About | Careers | Careers | About | Careers | Careers | About | About
Symbol: ATRA
Recent Price: $13.28
Industry: Biotechnology
CEO: Dr. Anhco Nguyen Ph.D.
Sector: Healthcare
Employees: 165
Address: 611 Gateway Boulevard, South San Francisco, CA 94080
Phone: 650 278 8930
Last updated: 2024-12-31
BioVie Inc.
BIV201, NE3107
Bio Vie Inc., a clinical stage biotechnology company, focuses on discovering, developing, and commercializing drug therapies in the United States, with products targeting liver cirrhosis, Alzheimer's, Parkinson's, multiple myeloma, and prostate cancer.
Symbol: BIVI
Recent Price: $2.09
Industry: Biotechnology
CEO: Mr. Cuong Viet Do M.B.A.
Sector: Healthcare
Employees: 14
Address: 680 West Nye Lane, Carson City, NV 89703
Phone: 775 888 3162
Last updated: 2024-12-31
bluebird bio, Inc.
betibeglogene autotemcel, lovotibeglogene autotemcel, elivaldogene autotemcel
bluebird bio, Inc. is a biotechnology company that researches, develops, and commercializes transformative gene therapies for severe genetic diseases, including treatments for ß-thalassemia, sickle cell disease, and cerebral adrenoleukodystrophy.
About | Leadership | DEI | About | About | About | Contact | Careers | About | About | About | About
Symbol: BLUE
Recent Price: $7.86
Industry: Biotechnology
CEO: Mr. Andrew Obenshain
Sector: Healthcare
Employees: 375
Address: 60 Binney Street, Cambridge, MA 02142
Phone: 339 499 9300
Leadership
- Sarah Alspach, Senior Vice President, External Affairs
- Rich Colvin, MD, PhD, Chief Medical Officer
- Kasra Kasraian, Senior Vice President, Technical Development and Operations
- Tom Klima, Chief Commercial & Operating Officer
- Andrew Obenshain, Chief Executive Officer
- Scott Shoemaker, Senior Vice President, Quality
- James Sterling, Chief Financial Officer
- Joe Vittiglio, Chief Business and Legal Officer
- Andrea Walton, Chief People Officer
- Leslie Wilder, Vice President, Head of Regulatory Science
- Mark Vachon, Chairman; Formerly of GE
- John O. Agwunobi, M.D., Formerly of Herbalife Nutrition
- Mike Cloonan, President and Chief Executive Officer, Sionna Therapeutics
- Charlotte Jones-Burton, M.D., Formerly of Chinook Therapeutics
- Lis Leiderman, M.D., CHIEF FINANCIAL OFFICER & CORPORATE DEVELOPMENT OFFICER AT DEWPOINT THERAPEUTICS
- Nick Leschly, Former Chief Kairos Officer, 2seventy Bio
- Richard Paulson, President and Chief Executive Officer at Karyopharm Therapeutics Inc.
- Najoh Tita-Reid, Chief Brand and Experience Officer, Mars Petcare
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
Gossamer Bio, Inc.
GB002, GB004, GB5121, GB7208
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics in immunology, inflammation, and oncology. Key products in development include GB002 for pulmonary arterial hypertension, GB004 for inflammatory bowel disease, GB5121 for primary central nervous system lymphoma, and GB7208 for multiple sclerosis.
About | About | Management | Directors | Contact | Locations | Contact | Contact | About | About
Symbol: GOSS
Recent Price: $0.88
Industry: Biotechnology
CEO: Mr. Faheem Hasnain
Sector: Healthcare
Employees: 135
Address: 3013 Science Park Road, San Diego, CA 92121
Phone: 858 684 1300
Leadership
- Faheem Hasnain, Chairman
- Richard Aranda, M.D., Chief Medical Officer
- Jeff Boerneke, General Counsel and Secretary
- Matt Cravets, Senior Vice President, Biometrics
- Bryan Giraudo, Chief Operating Officer & Chief Financial Officer
- Lisa Nolan, Ph.D., Managing Director and President, Gossamer Bio Ireland
- Caryn Peterson, Executive Vice President, Regulatory Affairs
- Bob Smith, Chief Commercial Officer
- Christian Waage, Executive Vice President, Technical Operations & Administration
- Deanna Weber, Senior Vice President, Human Resources
- Russell J. Cox, Director
- Thomas Daniel, Director
- Skye Drynan, Director
- Sandra Milligan, Director
- Steven D. Nathan, Director
- John Quisel, Director
Last updated: 2024-12-31
IGM Biosciences, Inc.
IGM-2323
IGM Biosciences, Inc. is a biotechnology company focused on developing Immunoglobulin M (Ig M) antibodies for treating cancer, infectious diseases, and autoimmune and inflammatory diseases. Their lead product candidate, IGM-2323, is in Phase 2 clinical trials for B cell Non-Hodgkin's lymphoma.
Symbol: IGMS
Recent Price: $6.05
Industry: Biotechnology
CEO: Ms. Mary Beth Harler M.D.
Sector: Healthcare
Employees: 204
Address: 325 East Middlefield Road, Mountain View, CA 94043
Phone: 650 965 7873
Last updated: 2024-12-31
Inovio Pharmaceuticals, Inc.
DNA Medicines
Inovio Pharmaceuticals is a biotechnology company focused on discovering, developing, and commercializing DNA medicines to treat and protect against diseases like HPV, cancer, and infectious diseases. Their platform includes Syn Con designed DNA sequences and CELLECTRA smart devices technology for delivery.
Vision/Values | Leadership | About | Leadership | Vision/Values | About | Contact | Careers | Careers | About | About | About | About | About
Symbol: INO
Recent Price: $1.78
Industry: Biotechnology
CEO: Dr. Jacqueline E. Shea Ph.D.
Sector: Healthcare
Employees: 127
Address: 660 West Germantown Pike, Plymouth Meeting, PA 19462
Phone: 267 440 4200
Leadership
- Jacqueline Shea, Ph.D., President & Chief Executive Officer
- Peter Kies, Chief Financial Officer
- Michael Sumner, MB BS, MBA, Chief Medical Officer
- Laurent Humeau, Ph.D., Chief Scientific Officer; Chairman, Scientific Advisory Board
- Steve Egge, MBA, Chief Commercial Officer
- Rob Crotty, J.D., General Counsel and Chief Compliance Officer
- EJ Brandreth, MBA, Senior Vice President, Quality Assurance
- Shawn Bridy, MA, MBA, Senior Vice President, Business Development
- Cheryl Elder, PharmD, Senior Vice President, Regulatory Affairs
- Robert J. Juba Jr., Senior Vice President, Biological Manufacturing and Clinical Supply Management
- Jeffrey Skolnik, M.D., Senior Vice President, Clinical Development
- Dave Liebowitz, M.D. & Ph.D., Senior Vice President, Early-Stage Clinical Development
- Simon X. Benito, Chairman of the Board, Inovio Pharmaceuticals
- Roger D. Dansey, M.D., Chief Medical Officer at Seagen
- Ann C. Miller, M.D., Former Head of Sanofi Oncology Global Marketing
- Jay Shepard, Former President & CEO of Aravive
- David B. Weiner, Ph.D., Executive Vice President, Director, Vaccine Center, The Wistar Institute
- Wendy L. Yarno, MBA, Former Executive Vice President and Chief Marketing Officer at Merck & Co., Inc.
- Lota S. Zoth, CPA, Former Chief Financial Officer, MedImmune
- Rafi Ahmed, Ph.D., Director, Emory Vaccine Center, Emory University School of Medicine
- Stanley A. Plotkin, M.D., Emeritus Professor, Wistar Institute and University of Pennsylvania; Principal, Vaxconsult
Last updated: 2024-12-31
Intensity Therapeutics, Inc.
INT230-6
Intensity Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of cancer drugs for treating solid tumors. Their lead product, INT230-6, is undergoing Phase 2 trials for various cancers and is being tested in collaborations with major pharmaceutical companies.
Symbol: INTS
Recent Price: $1.82
Industry: Biotechnology
CEO: Mr. Lewis H. Bender M.A., M.B.A., M.S.
Sector: Healthcare
Employees: 5
Address: 61 Wilton Road, Westport, CT 06880
Phone: 203 221 7381
Leadership
- Lewis H. Bender, M.S., M.A., M.B.A., Founder and CEO
- Joseph Talamo, CPA, Chief Financial Officer
- James M. Ahlers, Executive Vice President
- Brian Schwartz, MD, Executive VP, Clinical Development
- John Wesolowski, CPA, MBA, Principal Accounting Officer and Controller
- Kimberly A. Guedes, RN, MBA, Vice President of Clinical Operations
- Doranne Frano, Regulatory Affairs and Quality Control
- Daniel J. Donovan, Board Member and Chief Executive Officer
- Tom Dubin, Board Member
- Mark A. Goldberg, MD, Board Member
- Emer Leahy, Ph.D., Board Member
Last updated: 2024-12-31
INVO Bioscience, Inc.
INVOcell
INVO Bioscience, Inc. is a fertility company providing assisted reproductive technology solutions with its flagship product, INVOcell, promoting in vivo fertilization and early embryo development. The company aims to make fertility care more accessible worldwide.
Symbol: INVO
Recent Price: $0.83
Industry: Medical - Devices
CEO: Mr. Steven M. Shum
Sector: Healthcare
Employees: 25
Address: 5582 Broadcast Court, Sarasota, FL 34240
Phone: 978 878 9505
Last updated: 2024-12-31
Renovaro Biosciences Inc.
RENB-HV-01, RENB-HV-12, RENB-HB-01, RENB-DC-11, RENB-DC-12-XX, RENB-HV-21
Renovaro Biosciences Inc. is a pre-clinical stage biotechnology company focused on R&D of pharmaceutical and biological products for treating HIV, HBV, and cancer in the U.S. The company has a robust product pipeline and strategic partnerships, and was formerly known as Enochian Biosciences, Inc.
Symbol: RENB
Recent Price: $0.87
Industry: Biotechnology
CEO: Mr. David H. Weinstein
Sector: Healthcare
Employees: 25
Address: 2080 Century Park East, Los Angeles, CA 90067
Phone: 305 918 1980
Last updated: 2024-12-31
Instil Bio, Inc.
ITIL-168, ITIL-306
Instil Bio, Inc. is a clinical-stage biopharmaceutical company that develops cell therapies for treating cancer patients, focusing on autologous tumor infiltrating lymphocyte (TIL) treatments.
Symbol: TIL
Recent Price: $18.99
Industry: Biotechnology
CEO: Mr. Bronson Crouch
Sector: Healthcare
Employees: 49
Address: 3963 Maple Avenue, Dallas, TX 75219
Phone: 972 499 3350
Last updated: 2024-12-31
2seventy bio, Inc.
idecabtagene vicleucel
2seventy bio, Inc. is a cell and gene therapy company focusing on cancer treatment research, development, and commercialization, with products including idecabtagene vicleucel and collaborations with Bristol-Myers Squibb.
Symbol: TSVT
Recent Price: $2.89
Industry: Biotechnology
CEO: Mr. William D. Baird III, M.B.A.
Sector: Healthcare
Employees: 274
Address: 60 Binney Street, Cambridge, MA 02142
Phone: 339 499 9300
Last updated: 2024-12-31
Abeona Therapeutics Inc.
EB-101
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa.
Symbol: ABEO
Recent Price: $5.61
Industry: Biotechnology
CEO: Dr. Vishwas Seshadri M.B.A., Ph.D.
Sector: Healthcare
Employees: 84
Address: 1330 Avenue of the Americas, New York, NY 10019
Phone: 646 813 4701
Last updated: 2024-12-31
Galecto, Inc.
GB2064
Galecto, Inc. is a clinical-stage biotechnology company focused on developing molecules for the treatment of fibrosis, cancer, inflammation, and related diseases. Their lead product candidate, GB2064, is in Phase IIa for myelofibrosis. The company also advances other candidates targeting severe fibrotic lung diseases and cancer.
Symbol: GLTO
Recent Price: $4.60
Industry: Biotechnology
CEO: Dr. Hans T. Schambye M.D., Ph.D.
Sector: Healthcare
Employees: 13
Address: 75 State Street, Boston, MA 02109
Phone: 457 070 5210
Last updated: 2024-12-31
IN8bio, Inc.
INB-200, INB-100, INB-400, INB-300
IN8bio, Inc. is a clinical-stage biotechnology company focused on gamma-delta T cell therapies for cancer treatment, with lead products in clinical trials and preclinical development.
Symbol: INAB
Recent Price: $0.27
Industry: Biotechnology
CEO: Mr. Tai-Wei Ho
Sector: Healthcare
Employees: 39
Address: 350 5th Avenue, New York, NY 10118
Phone: 646 600 6438
Last updated: 2024-12-31
Tango Therapeutics, Inc.
TNG908
Tango Therapeutics, Inc. is a biotechnology company focused on discovering and developing drugs for cancer treatment, with a lead program TNG908 targeting cancers with methylthioadenosine phosphorylase deletions. The company also works on therapies for BRCA1/2-mutant and STK11-mutant cancers and collaborates with Gilead Sciences, Inc.
Symbol: TNGX
Recent Price: $3.10
Industry: Biotechnology
CEO: Dr. Barbara L. Weber M.D.
Sector: Healthcare
Employees: 140
Address: 100 Binney Street, Cambridge, MA 02142
Phone: 857 320 4900
Last updated: 2024-12-31